off label use is the biggest threat of course. just one approval and its "off" to the races literally. the "hold" was BS and we all know it, stall tactic at best. the off label use for long covid ( me ) alone could be massive, dont know too many people that can claim covid has entirely left their system. let alone the aftershock of the so called "vaccines", which hit me almost as hard as actual covid.

im at my 4th bout currently and brain fog, exhaustion and other mysteries are rampant. many are way worse off than me and LL could very well be a key to unlock this medium level ever-present discomfort for good. bring it on.

lets hope dr j enjoys his experience and decides he wants to be ceo long term. if anything, i trust him.

Quote:

---

Really interesting as to how big CYDY could be after first approval of anything since off label sales could be the biggest thing ever. Look at Humara as good example or look at the relatively new diabetes drug Ozempic was approved for diabetes how ever change the name and tens of thousands more taking it for weight loss under different name.

Read More: https://investorshangout.com/post/newpost/605...z8MTBPzChx

---